Search Within

Viswatej Avutu

Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Guidelines (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Hematology-Oncology Fellows (36)
  2. Department of Medicine (31)
  3. Solid Tumor Oncology Division (31)
  4. Sarcoma Service (30)
  5. Hematologic Malignancies, Division of (22)
  6. Weinberg Fellows (21)

More Groups

People
  1. William Tap (24)
  2. Mark Dickson (21)
  3. Ciara Kelly (20)
  4. Mary Keohan (20)
  5. Mrinal Gounder (20)
  6. Sandra D'Angelo (20)

More People

Years
  1. 2025 (6)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (1)
  6. 2020 (4)
Publications
  1. Journal of Clinical Oncology (16)
  2. Journal for ImmunoTherapy of Cancer (3)
  3. Journal of Adolescent and Young Adult Oncology (3)
  4. Annals of Oncology (2)
  5. Clinical Cancer Research (2)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. American Association for Cancer Research (3)
  3. Biomed Central Ltd (3)
  4. Mary Ann Liebert, Inc (3)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I trial of CRD3874-SI, a systemically administered STING agonist, in patients with advanced solid tumors
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; Clark, C.; Counihan, O.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)
    Journal Article

    Hesko, C.; Mittal, N.; Avutu, V.; Thomas, S. M.; Heath, J. L.; Roth, M. E.
    Current Problems in Cancer (2023)

    Fulltext@MSK | Save
  • Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
    Research Letter

    Whiteway, S. L.; Weiss, A. R.; Ahmed, S. K.; Allen-Rhoades, W. A.; Avutu, V.; Cardona, K.; Davis, L. E.; Davis, E. J.; Indelicato, D. J.; Isakoff, M. S.; more...
    Journal of Adolescent and Young Adult Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte MeĢrida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save